Reduced CD27 Expression on Antigen-Specific CD4+ T Cells Correlates with Persistent Active Tuberculosis

被引:32
|
作者
Jiang, Jing [1 ,2 ]
Wang, Xianyuan [1 ]
Wang, Xinjing [2 ]
Cao, Zhihong [2 ]
Liu, Yanhua [2 ]
Dong, Mei [3 ]
Tong, Aihua [3 ]
Cheng, Xiaoxing [2 ]
机构
[1] Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China
[2] Inst TB, Div Res, Beijing 100091, Peoples R China
[3] Dept Lab Med, Beijing, Peoples R China
基金
北京市自然科学基金;
关键词
CD4(+) T cells; CD27; tuberculosis; biomarker; persistent infection; IFN-GAMMA; IN-VIVO; CD154; EXPRESSION; MEMORY; LYMPHOCYTES; IMMUNITY; SUBSETS; DISEASE; LIGAND; CD70;
D O I
10.1007/s10875-010-9418-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD27, a member of the tumor necrosis factor receptor family, has important role in generation of T cell immunity. In this study, association of CD27 expression on mycobacterial antigen-specific CD4(+) T cells with pulmonary tuberculosis (TB) was investigated. Mycobacterial antigen-specific CD4(+) T cells were identified based on CD154 expression and CD27 expression on antigen-specific CD4 T cells was analyzed by flow cytometry. Compared with tuberculin-positive controls, patients with bacterial culture-positive pulmonary TB had significantly reduced CD27 expression on antigen-specific CD4 T cells. The persistent active TB patients had much lower percentages of CD27(+) antigen-specific CD4 T cells than culture-positive new TB patients (P = 0.008) and healthy controls (P = 0.005). Logistic regression analysis on frequencies of CD27-expressing antigen-specific CD4 T cells and TB patients' clinical characteristics indicated that low percentage of CD27(+) antigen-specific CD4 T cells correlated significantly with persistent active tuberculosis (P = 0.002, odds ratio = 19.6). It is concluded that frequency of CD27(+) antigen-specific CD4 T cells could be used as an immunological marker for persistent active TB.
引用
收藏
页码:566 / 573
页数:8
相关论文
共 50 条
  • [21] Polyfunctional Mycobacterium tuberculosis-specific effector memory CD4+ T cells at sites of pleural TB
    El Fenniri, L.
    Toossi, Z.
    Aung, H.
    El Iraki, G.
    Bourkkadi, J.
    Benamor, J.
    Laskri, A.
    Berrada, N.
    Benjouad, A.
    Mayanja-Kizza, H.
    Betts, M. R.
    El Aouad, R.
    Canaday, D. H.
    TUBERCULOSIS, 2011, 91 (03) : 224 - 230
  • [22] CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion
    Deng, Yun
    Chatterjee, Bithi
    Zens, Kyra
    Zdimerova, Hana
    Muller, Anne
    Schuhmachers, Patrick
    Ligeon, Laure-Anne
    Bongiovanni, Antonino
    Capaul, Riccarda
    Zbinden, Andrea
    Holler, Angelika
    Stauss, Hans
    Hammerschmidt, Wolfgang
    Muenz, Christian
    BLOOD, 2021, 137 (23) : 3225 - 3236
  • [23] A universal MHCII technology platform to characterize antigen-specific CD4+ T cells
    Vyasamneni, Rohit
    Kohler, Victoria
    Karki, Binisha
    Mahimkar, Gauri
    Esaulova, Ekaterina
    McGee, Jonathan
    Kallin, Daniel
    Sheen, Joong Hyuk
    Harjanto, Dewi
    Kirsch, Miles
    Poran, Asaf
    Dong, Jesse
    Srinivasan, Lakshmi
    Gaynor, Richard B.
    Bushway, Meghan E.
    Srouji, John R.
    CELL REPORTS METHODS, 2023, 3 (01):
  • [24] Lung Neutrophils Facilitate Activation of Naive Antigen-Specific CD4+ T Cells during Mycobacterium tuberculosis Infection
    Blomgran, Robert
    Ernst, Joel D.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (12) : 7110 - 7119
  • [25] Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages
    Yang, Jason D.
    Mott, Daniel
    Sutiwisesak, Rujapak
    Lu, Yu-Jung
    Raso, Fiona
    Stowell, Britni
    Babunovic, Greg Hunter
    Lee, Jinhee
    Carpenter, Steve M.
    Way, Sing Sing
    Fortune, Sarah M.
    Behar, Samuel M.
    PLOS PATHOGENS, 2018, 14 (05)
  • [26] Reviving Function in CD4+ T Cells Adapted to Persistent Systemic Antigen
    Noval Rivas, Magali
    Weatherly, Kathleen
    Hazzan, Marc
    Vokaer, Benoit
    Dremier, Sarah
    Gaudray, Florence
    Goldman, Michel
    Salmon, Isabelle
    Braun, Michel Y.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (07) : 4284 - 4291
  • [27] Broad clonal heterogeneity of antigen-specific CD4+ T-cells localizing at the site of disease during tuberculosis
    Dieli, F
    Sireci, G
    Ivanyi, J
    Singh, M
    Friscia, G
    Di Sano, C
    Spallek, R
    Salerno, A
    IMMUNOLOGY LETTERS, 1999, 69 (03) : 311 - 315
  • [28] CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells
    Zhu, Ziqiang
    Cuss, Steven M.
    Singh, Vinod
    Gurusamy, Devikala
    Shoe, Jennifer L.
    Leighty, Robert
    Bronte, Vincenzo
    Hurwitz, Arthur A.
    JOURNAL OF IMMUNOLOGY, 2015, 195 (07) : 3482 - 3489
  • [29] Depletion of conventional CD4+ T cells is required for robust priming and dissemination of tumor antigen-specific CD8+ T cells in the setting of anti-CD4 therapy
    Ramirez, Delaney E.
    Dragnev, Christo P. C.
    Searles, Tyler G.
    Spicer, Nathaniel
    Chen, Tiffany
    Lines, J. Louise
    Hawkes, Aaron R.
    Davis, Wilson L.
    Mohamed, Asmaa
    Shirai, Keisuke
    Phillips, Joseph D.
    Rosato, Pamela C.
    Huang, Yina H.
    Turk, Mary Jo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [30] HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients
    Tippalagama, Rashmi
    Singhania, Akul
    Dubelko, Paige
    Arlehamn, Cecilia S. Lindestam
    Crinklaw, Austin
    Pomaznoy, Mikhail
    Seumois, Gregory
    DeSilva, Aruna D.
    Premawansa, Sunil
    Vidanagama, Dhammika
    Gunasena, Bandu
    Goonawardhana, N. D. Suraj
    Ariyaratne, Dinuka
    Scriba, Thomas J.
    Gilman, Robert H.
    Saito, Mayuko
    Taplitz, Randy
    Vijayanand, Pandurangan
    Sette, Alessandro
    Peters, Bjoern
    Burel, Julie G.
    JOURNAL OF IMMUNOLOGY, 2021, 207 (02) : 523 - 533